Pharmaceuticals Financial News

01.01 / 01:23

markets Digital Manufacturing Strategy PAM Pharmaceuticals Erring drug companies to face stricter action as rules to improve mfg standards come into effect today

01.01 / 00:59

markets Target trends Trade show recommendations Pharmaceuticals Stocks to buy: Raja Venkatraman recommends three stocks for today—1 January

Subscribe to enjoy similar stories. Wishing all our readers a very Happy New Year! As 2024 drew to a close, markets grappled with significant challenges: geopolitical instability, underwhelming Q2 earnings, foreign institutional investor (FII) outflows, volatility from central bank rate cuts, and tariff concerns over Donald Trump's policies.

31.12 / 01:11

Target Strategy economy Healthcare performer 2020 Pharmaceuticals Mint Primer: Climate targets: How do Nifty-50 companies fare?

Subscribe to enjoy similar stories. Out of the Nifty-50 constituents, an alarming 19 companies are yet to publicly state a target year for becoming net-zero emitters or carbon neutral. Another 20 companies have publicly announced a net-zero target and 11 have committed to a carbon neutral target year.

30.12 / 13:59

markets UPS NXP wellness Trade innovations Pharmaceuticals 10 stocks to watch in 2025

With a Goldilocks economy and a bull market charging into a second year, 2024 shaped up to be a good year for investors.

30.12 / 11:35

markets Analysis Research Trade Experts Updates Pharmaceuticals Stock market update: Nifty Pharma index 1.01%

Shares of Biocon Ltd.(up 4.3 per cent), Lupin Ltd.(up 3.76 per cent), Divi's Laboratories Ltd.(up 2.79 per cent), Aurobindo Pharma Ltd.(up 2.24 per cent) and J B Chemicals & Pharmaceuticals Ltd.(up 2.12 per cent) ended the day as top gainers in the pack.

30.12 / 03:59

markets IPO Booking Experts recommendations Updates Pharmaceuticals Senores Pharmaceuticals Share Price Live Updates: GMP, experts signal strong debut on Indian stock market today

₹284, suggesting the shares could list ₹284 above the issue price of ₹391. At this GMP and IPO price, Senores Pharma shares could list at ₹675, a premium of 73% over IPO price.Senores Pharmaceuticals Share Price Live: Senores Pharmaceuticals IPO was subscribed 93.69 times subscription in total as it garnered bids for 79.95 crore equity shares as against 85.34 lakh shares on the offer.

30.12 / 02:51

markets IPO Analysis Trade Experts hospital Pharmaceuticals Ola Electric shares in focus after CTO and CMO resign amid leadership exodus

Ola Electric will remain in focus on Monday following the resignations of two senior executives, Chief Technology and Product Officer Suvonil Chatterjee and Chief Marketing Officer Anshul Khandelwal, effective Friday. Both Chatterjee and Khandelwal had longstanding tenures at Bhavish Aggarwal-led Ola, initially joining Ola Cabs before transitioning to Ola Electric. Chatterjee joined as Head of Design in 2017, while Khandelwal began in 2018 as Head of Marketing. Their departures add to a series of top-level exits from Ola’s businesses, including AI venture Krutrim, this year.

30.12 / 02:51

markets IPO Analysis Trade Experts band Pharmaceuticals Senores Pharma IPO listing today. GMP hints at solid gains on debut

Senores Pharmaceuticals will debut on the exchanges on Monday. Ahead of the listing, the company's shares were trading with a GMP of Rs 284 in the grey market. Considering the upper price band of Rs 391, the stock is expected to list at a premium of 70% or above the issue price.

26.12 / 12:23

markets Manufacturing Strategy Software Experts PAM Pharmaceuticals Akums enters into Rs 1750 crore contract to supply pharma products to Europe

global pharmaceutical company to manufacture and supply pharmaceutical formulations in the European market.

26.12 / 05:57

Career Platform Strategy WhatsApp Matrix recommendations Pharmaceuticals Godfrey Phillips appoints Siddharth Chawla as new COO

Godfrey Phillips India, one of the leading tobacco and FMCG companies in India, announced on Thursday the appointment of Siddharth Chawla as its new Chief Operating Officer (COO), to be effective from January 7, 2025, or another mutually agreed-upon date.

26.12 / 05:57

markets Analysis Trade Experts Updates Pharmaceuticals Stock market update: Nifty Pharma index 0.04% in an upbeat market

Lupin Ltd.(up 1.11 per cent), Gland Pharma Ltd.(up 0.65 per cent), Cipla Ltd.(up 0.35 per cent), Sun Pharmaceutical Industries Ltd.(up 0.26 per cent) and Dr. Reddy's Laboratories Ltd.(up 0.26 per cent) were among the top gainers.

26.12 / 01:19

markets COST Strategy wellness Healthcare performer Pharmaceuticals Top sectors to pick and avoid in 2025

Subscribe to enjoy similar stories. Mint spoke with wealth management experts to identify their top investment picks and strategies for 2025. Financial services stocks emerged as a favourite, driven by their reasonable valuations and the potential boost from monetary stimulus, which could revive credit growth and stabilize margins.

25.12 / 14:41

markets Strategy Software economy PAM Department Pharmaceuticals Arunish Chawla named revenue secretary, Manipur CS Vineet Joshi to be higher education secretary

Arunish Chawla has been appointed the revenue secretary as part of a top-level bureaucratic reshuffle effected by the Centre on Wednesday. Chawla, a 1992 batch Indian Administrative Service (IAS) officer of the Bihar cadre, is currently the pharmaceuticals secretary. He has been appointed secretary, Department of Revenue, Ministry of Finance, according to a personnel ministry order.

25.12 / 08:45

markets COST UPS Strategy trends rights Pharmaceuticals Fed's rate cuts and hawkish outlook: Implications for Indian markets

The US Federal Reserve's decision to cut interest rates by 25 basis points (bps) in its December 2024 policy meeting has raised questions about how this move might influence India’s monetary policy and asset classes. This is the third consecutive rate cut by the Fed in 2024, bringing the benchmark interest rate to the range of 4.25%-4.50%. However, the Fed has signalled a slower pace of easing in 2025, envisioning only two rate cuts as inflation remains “somewhat elevated".

25.12 / 04:31

MET CEO Election Intuit 2020 donates Pharmaceuticals The big companies funding Trump’s inauguration despite denouncing Jan 6

Subscribe to enjoy similar stories. Four years ago, dozens of companies denounced the invasion of the U.S. Capitol and pledged to withhold support from those who disputed the 2020 election results.

25.12 / 00:15

UPS Healthcare AbbVie hospital travelers patient Pharmaceuticals Mint Primer: Why are docs in the dock over a ‘work trip’?

Subscribe to enjoy similar stories. In May 2024, the DoP received an anonymous complaint alleging AbbVie Healthcare India flew 30 doctors—experts in Botox and Juvederm—to Paris and Monaco. It said the firm treated the doctors to “extravagant pleasure trips under the guise of conferences", that AbbVie purportedly flew doctors to a medical conference held in these locations.

24.12 / 18:41

markets Manufacturing Action PAM Courts Pharmaceuticals Karnataka HC stays action against drug units making Nutraceuticals

Karnataka High Court has directed the government to refrain from taking any action against companies manufacturing nutraceuticals in units licensed for drug production until its next hearing, in a significant relief for the pharmaceutical industry.

24.12 / 12:15

markets Strategy Analysis Trade Updates International Pharmaceuticals Stock market update: Nifty Pharma index 0.06%

Shares of Biocon Ltd.(up 4.54 per cent), Granules India Ltd.(up 1.74 per cent), Gland Pharma Ltd.(up 0.84 per cent), Aurobindo Pharma Ltd.(up 0.76 per cent) and Dr. Reddy's Laboratories Ltd.(up 0.72 per cent) ended the day as top gainers in the pack.

24.12 / 09:07

markets COST UPS Strategy trends rights Pharmaceuticals Fed's rate cuts and hawkish outlook: Implications for Indian markets

Subscribe to enjoy similar stories. The US Federal Reserve's decision to cut interest rates by 25 basis points (bps) in its December 2024 policy meeting has raised questions about how this move might influence India’s monetary policy and asset classes. This is the third consecutive rate cut by the Fed in 2024, bringing the benchmark interest rate to the range of 4.25%-4.50%.

24.12 / 09:07

markets COST UPS Research country patient Pharmaceuticals Competition will make weight-loss drugs better, cheaper and bigger

Subscribe to enjoy similar stories. Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Since May it has offered its own version of Wegovy, a blockbuster slimming jab, thanks to a quirk in American law that lets pharmacies replicate some brand-name drugs when there are shortages.

24.12 / 06:19

markets security show performer stage Pharmaceuticals 2025: The pharma stock poised to outperform

Subscribe to enjoy similar stories. Merry Christmas to all our readers! As we step into the final stretch of 2024, it’s time to reflect on the market’s journey, analyse the highs and lows, and contemplate the road ahead. In the 52nd week of 2024, the market continues to show its characteristic twists and turns, leaving everyone asking: what does 2025 hold? Read this | Home remedy: Indian pharma bets on domestic brands to combat US generics slowdown The Nifty50 index recorded a commendable gain of approximately 9% for 2024.

frequently asked questions about Pharmaceuticals

What is Pharmaceuticals and why is it relevant?

Pharmaceuticals is a significant category that is in the spotlight. On our site, we regularly publish news related to this subject.

Where can I find the latest updates on Pharmaceuticals?

All latest articles about Pharmaceuticals can be found in the special selection. We publish information regularly.

How can I verify the accuracy of information on Pharmaceuticals?

We rely on trusted sources to ensure that the information about Pharmaceuticals is reliable and helpful for our readers.